Diagnostics in Their Pockets

A device about the size of a smartphone is enabling cardiologists to generate images of patients’ hearts at the point of care, enabling them to make more informed diagnoses and even intervene earlier. The result? Improved care and outcomes, and possibly even reduced health care costs. The device is

New Granting Body to Make Major Investment in Arrhythmia Research

Arrhythmias — disturbances of the heart’s normal rhythm—affect more than 1.5 million Canadians and can impact a person’s health and well-being in a variety of ways. Sudden cardiac death caused by an arrhythmia kills 40,000 people every year. An estimated 350,000 Canadians are living with atrial

Pneumonia a Risk Factor for Heart Disease

Hospitalization for pneumonia is a significant risk factor for cardiovascular disease (CVD) in middle-aged and older adults with no history of heart disease, according to a study recently published in the Journal of the American Medical Association. Presenting his findings at the University of

Completing the Cardiac Imaging Fleet with MRI

In October, a crane carefully lowered the University of Ottawa Heart Institute’s first dedicated magnetic resonance imaging (MRI) scanner into a narrow access way so that it could be rolled through the exterior wall of the building and into position. By early December, the new MRI facility was fully

Canadian Women’s Heart Health Centre Launched

Heart disease is different for women, and that difference is borne out in almost every aspect of the disease: the factors that lead to it, symptoms, diagnosis, treatment and even risk of death. In fact, heart disease kills more women worldwide than all cancers, tuberculosis, AIDS and malaria

CCC 2014: The Future of Cardiac Prevention and Rehabilitation

Cardiovascular prevention and rehabilitation underwent extensive change in the 20th century and continues to evolve rapidly. Andrew Pipe, MD, in his Terry Kavanagh Lecture at the 2014 Canadian Cardiovascular Congress, outlined a vision for "CVD Prevention and Rehabilitation in the 21st Century." To

CCC 2014: Mobile Devices and Information Technology for Improving Care

While modern medicine is heavily dependent on sophisticated technologies to diagnose and treat disease, health care generally lags behind other sectors in adopting advances in information technology. A number of presentations at the 2014 Canadian Cardiovascular Congress looked at ways in which

New Heart Failure Drug Promises to Improve Outcomes for Patients

More than half a million Canadians are living with heart failure and another 50,000 join their ranks each year. The standard treatment for heart failure has not changed for quite some time. Now, a new drug—so new that it’s identified only as LCZ696—is generating interest among cardiologists and

CCC 2014: Recent Advances in the Management of Atrial Fibrillation

Until the new oral anticoagulant (NOAC) drugs became available, beginning in 2009, warfarin was the workhorse for managing stroke risk in patients with atrial fibrillation. In his Research Achievement Award presentation, Stuart Connolly, MD, of McMaster University in Hamilton, Ont., provided a

CCC and AHA 2014: Overcoming Challenges to Repair Heart Attack Damage

We know the best ways to prevent a heart attack. Healthy eating, being physically active and not smoking are key among them. And advances in cardiac care are helping people live longer and with a better quality of life if they do have a heart attack. But there is no way to repair the damage and